Inactive Instrument

Cerebain Biotech Corp.

CBBT

US15672M1062

Biotechnology & Medical Research

Cerebain Biotech Corp. has Changed its Ticker to CBBT from DDOO

June 19, 2014 at 02:00 pm

Cerebain Biotech Corp. changed its OTC Bulletin Board stock ticker symbol to CBBT from DDOO.

Latest news about Cerebain Biotech Corp.

Diabetes Reversal Group, LLC announced that it has received funding from Cerebain Biotech Corp.	28/09/22	CI
Cerebain Biotech Corp. completed the acquisition of Assets of PKG, Inc.	19/09/21	CI
Cerebain Biotech Corp. entered into a Letter of Intent to acquire Assets of PKG, Inc.	24/08/20	CI
Cerebain Biotech Corp Announces Resignation of Wesley D. Tate as Chief Financial Officer, Chief Operating Officer and as Member of Its Board of Directors	23/07/19	CI
Cerebain Biotech Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2019	20/05/19	CI
Cerebain Biotech Corp. announced that it expects to receive $0.11 million in funding from Auctus Fund Management, LLC	14/03/19	CI
Cerebain Biotech Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2018	19/02/19	CI
Cerebain Biotech Corp. announced that it has received $0.05 million in funding from Jefferson Street Capital LLC	09/12/18	CI
Cerebain Is Considering Multiple Strategic Alternatives	04/12/18	CI
Cerebain Biotech Corp. Auditor Raises 'Going Concern' Doubt	25/09/18	CI
Cerebain Biotech Corp. Auditor Raises 'Going Concern' Doubt	14/09/17	CI
Cerebain Biotech Corp. announced that it has received $0.1 million in funding	23/07/17	CI
Cerebain Biotech Corp. announced that it expects to receive $0.1 million in funding	28/06/17	CI
Cerebain Biotech May Look At Strategic Alternatives	09/03/17	CI
Cerebain Biotech Corp. Auditor Raises 'Going Concern' Doubt	26/09/16	CI
Cerebain Biotech and Mossakowski Medical Research Centre Sign Memorandum of Understanding	23/06/16	CI
Cerebain Biotech Announces Business Relocation into the Heart of Orange County, California	04/05/16	CI
Cerebain Biotech Announces Plans to Seek FDA Approval	27/04/16	CI
Cerebain Biotech Names Azad L. Sheikh to Scientific Advisory Board	12/04/16	CI
Cerebain Biotech Corp. announced that it has received $0.3 million in funding from Geronimo Middle East and Africa	07/06/15	CI
Cerebain Biotech Appoints Mustafa Husain to Scientific Advisory Board	29/01/15	CI
Cerebain Biotech Corp. will Change its Ticker to CBBT from DDOO.D	18/07/14	CI
Discount Dental Materials Inc has Changed its Name to Cerebain Biotech Corp	20/06/14	CI
Cerebain Biotech Corp. has Changed its Ticker to CBBT from DDOO	19/06/14	CI
Discount Dental Materials, Inc. has Changed its Name to Cerebain Biotech Corp	19/06/14	CI

Cerebain Biotech Corp. is a biomedical company. The Company operates as a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device. The Company, through its subsidiary, Cerebain Operating, Inc., is involved in the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Omentum is a layer of tissue lying over internal organs (such as the intestines) and has the ability to generate biological agents that nourish nerves and help them grow. The Company is focused on inclusion of both a medical device solution, as well as a synthetic drug solution in its products. The Company is in the process of preparing for initial clinical trials.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+64.92%	62.59B
IQVIA HOLDINGS INC.	-1.85%	41.18B
LONZA GROUP AG	+44.76%	40.29B
CELLTRION, INC.	-8.93%	27.9B
ICON PUBLIC LIMITED COMPANY	+13.05%	26.21B
ALNYLAM PHARMACEUTICALS, INC.	-21.96%	19.09B
BIO-TECHNE CORPORATION	+4.21%	13.08B
UNITED THERAPEUTICS CORPORATION	+25.74%	12.26B
MEDPACE HOLDINGS, INC.	+27.42%	12.05B

Other Biotechnology & Medical Research